Literature DB >> 10989181

Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice.

P R Grigera1, M P Marzocca, A V Capozzo, L Buonocore, R O Donis, J K Rose.   

Abstract

We generated a recombinant vesicular stomatitis virus (VSV-E2) encoding the bovine viral diarrhea virus (BVDV) E2 glycoprotein with the VSV-G protein signal peptide. Infection of BHK21 cells with VSV-E2 induced the synthesis of a recombinant E2 (rE2) that comigrated with authentic BVDV-E2 in PAGE-SDS gels. Non-reducing immunoblots showed that rE2 is a disulfide bond-linked homodimer with at least 10-fold higher avidity for conformation-dependent anti-BVDV-E2 antibodies than its reduced monomeric counterpart. Immunofluorescence microscopy also showed that rE2 was transported to the plasma membrane of infected cells and analysis of purified particles demonstrated that dimeric rE2 was incorporated into VSV-E2 virions in approximately 1:10 ratio with respect to the G glycoprotein. BALB/c mice inoculated intranasally with VSV-E2 doses of up to 10(7) plaque forming units (pfu) showed no symptoms of viral-induced disease and developed a specific BVDV neutralizing response that lasted for at least 180 days post inoculation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989181     DOI: 10.1016/s0168-1702(00)00164-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

1.  Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Authors:  Michael Garbutt; Ryan Liebscher; Victoria Wahl-Jensen; Steven Jones; Peggy Möller; Ralf Wagner; Viktor Volchkov; Hans-Dieter Klenk; Heinz Feldmann; Ute Ströher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 2.  Rhabdoviruses as vectors for vaccines and therapeutics.

Authors:  Gabrielle Scher; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2020-10-29       Impact factor: 7.090

3.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

Authors:  Robert J Natuk; David Cooper; Min Guo; Priscilla Calderon; Kevin J Wright; Farooq Nasar; Susan Witko; Diane Pawlyk; Margaret Lee; Joanne DeStefano; Donna Tummolo; Aaron S Abramovitz; Seema Gangolli; Narender Kalyan; David K Clarke; R Michael Hendry; John H Eldridge; Stephen A Udem; Jacek Kowalski
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Expression of the genomic form of the bovine viral diarrhea virus E2 ORF in a bovine herpesvirus-1 vector.

Authors:  Lingshu Wang; J Charles Whitbeck; William C Lawrence; Denys V Volgin; Leonard J Bello
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

6.  Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression.

Authors:  Susan E Witko; J Erik Johnson; Narender K Kalyan; Barbara K Felber; George N Pavlakis; Maninder K Sidhu; R Michael Hendry; Stephen A Udem; Christopher L Parks
Journal:  J Virol Methods       Date:  2009-11-24       Impact factor: 2.014

7.  A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector.

Authors:  Lingshu Wang; Sreekumar Menon; Steven R Bolin; Leonard J Bello
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Characterisation of a New Molecule Based on Two E2 Sequences from Bovine Viral Diarrhoea-mucosal Disease Virus Fused To the Human Immunoglobulin Fc Fragment.

Authors:  Alaín González Pose; Raquel Montesino Seguí; Rafael Maura Pérez; Florence Hugues Salazar; Ignacio Cabezas Ávila; Claudia Altamirano Gómez; Oliberto Sánchez Ramos; Jorge Roberto Toledo
Journal:  J Vet Res       Date:  2021-01-26       Impact factor: 1.744

9.  Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.

Authors:  Arun V Iyer; Bapi Pahar; Marc J Boudreaux; Nobuko Wakamatsu; Alma F Roy; Vladimir N Chouljenko; Abolghasem Baghian; Cristian Apetrei; Preston A Marx; Konstantin G Kousoulas
Journal:  Vaccine       Date:  2008-12-12       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.